Zhongshan Lumigentek Lighting Technology Co., Ltd. – Trademark Portfolio
Entity Type: 16
Zhongshan Lumigentek Lighting Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include FEXONOVA and TORPHAEX. The owner is based in Guangdong Province.
4th Floor, Building A, 3 Nanfeng 1st St
Guzhen Town, Zhongshan City
Guangdong Province 528400 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zhongshan Lumigentek Lighting Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does Zhongshan Lumigentek Lighting Technology Co., Ltd. have?
Zhongshan Lumigentek Lighting Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Zhongshan Lumigentek Lighting Technology Co., Ltd. file in?
Zhongshan Lumigentek Lighting Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 11 (Environmental Control). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.
What are Zhongshan Lumigentek Lighting Technology Co., Ltd.'s most well-known trademarks?
Zhongshan Lumigentek Lighting Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as FEXONOVA and TORPHAEX. These are among 2 currently registered trademarks in the portfolio.
What is Zhongshan Lumigentek Lighting Technology Co., Ltd.'s trademark registration success rate?
Zhongshan Lumigentek Lighting Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.